<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Interleukin-8 (IL-8) also referred to as CXCL8, a member of the CXC chemokine family that attracts neutrophils and other leukocytes, has been associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_177'>Angiogenesis</z:mpath> is a prime regulator of <z:e sem="disease" ids="C1519678" disease_type="Neoplastic Process" abbrv="">tumour expansion</z:e> and data support that IL-8 is a potent angiogenic factor </plain></SENT>
<SENT sid="2" pm="."><plain>Epigenomic instability has been postulated to play a role for the development of multiple <z:hpo ids='HP_0002664'>neoplasias</z:hpo> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>DNA methylation of <z:chebi fb="1" ids="16040">cytosine</z:chebi> residues in CpG <z:chebi fb="0" ids="47885">dinucleotides</z:chebi> leads to transcriptional silencing of associated genes </plain></SENT>
<SENT sid="4" pm="."><plain>METHOD: In this study, we comparatively analysed the protein expression of IL-8 in plasma, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and paired <z:mpath ids='MPATH_458'>normal</z:mpath> tissue and methylation status of the IL-8 gene to evaluate its impact on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Collectively, by using Luminex technology, we noted a significantly higher IL-8 level in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue compared to paired <z:mpath ids='MPATH_458'>normal</z:mpath> tissue and that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients exhibit significantly higher plasma levels than healthy controls </plain></SENT>
<SENT sid="6" pm="."><plain>Analysed by methylation-specific polymerase chain reaction, we detected IL-8 hypomethylation in 64% of the cancerous tissue cases but no hypomethylation was found in paired <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="7" pm="."><plain>We noted that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with IL-8 hypomethylation revealed a significant higher level of IL-8 protein in cancerous tissue, which tended to be associated with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We also observed that patients with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> showed a significantly higher plasma level of IL-8 in relation to patients without distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our results suggest that the predominance of high plasma levels of IL-8 in patients with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in combination with the hypomethylation of the IL-8 promoter region might be a useful marker of the disease advancement </plain></SENT>
</text></document>